article thumbnail

Abu Dhabi DoH signs new deal to accelerate development in life sciences

Pharmaceutical Technology

The Abu Dhabi Department of Health (DoH) in the UAE has made a declaration of collaboration with Mass General Brigham’s (MGB) International Center for Genetic Disease (iCGD) to advance life sciences.

article thumbnail

Genomics England will move HQ to Canary Wharf’s new biocluster

pharmaphorum

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development. facility dedicated to a combination of wet lab and office space, revealed in March, intended as a focal point for life sciences companies in London.

Genome 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Interview with Asaf Zviran, CEO of Cancer Genomics Company C2i Genomics – Xtalks Life Science Podcast Ep. 74

XTalks

This episode features an interview with Dr. Asaf Zviran, CEO and co-founder of C2i Genomics, a biotech company focused on improving cancer detection and monitoring using genomics- and AI-based approaches. Zviran’s founded C2i Genomics, including a personal story, and how the company is focused on truly personalizing cancer treatments.

Genome 52
article thumbnail

Investment fuels AI-driven development of breakthrough genomic medicines

pharmaphorum

David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says.

Genome 105
article thumbnail

Seqera Labs partners with Genomics England to enhance genomic research capabilities

Drug Discovery Today

BARCELONA/LONDON, 25.05.23: Seqera Labs, the leading provider of secure workflow orchestration software in the life sciences sector, has partnered with Genomics England, the government-owned company that launched the 100,000 Genomes Project in partnership with the NHS.

Genome 45
article thumbnail

Interview with the Jones!Lab on development of novel genome editing tools

Drug Discovery Today

27, Vilnius will host the EFIB’2022 event which will bring the European life science sector together. In the field of life sciences, Lithuania is best known for the discovery of gene scissors by Prof. Lab, focused on research and development of novel genome editing tools. Virginijus Šikšnys.

Genome 85
article thumbnail

MAPLE: A phylogenetic tool for pandemic-scale genome data

Medical Xpress

With the huge abundance of genomic data generated from life science experiments, processing large datasets remains a challenge in the field of bioinformatics.

Genome 73